| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 6 3196-3204, Copyright © 1995 by American Association of Immunologists
ARTICLES |
J Borvak, CS Chou, K Bell, G Van Dyke, H Zola, O Ramilo and ES Vitetta
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235, USA.
The present studies were designed to further determine whether the CD25 marker could distinguish between cells productively and latently infected with HIV. This was accomplished by combining immunotoxin (IT)- mediated killing of CD25+ cells, highly sensitive indirect immunofluorescence to detect remaining CD25+ cells, and PCR-mediated amplification of proviral DNA in immunotoxin-treated vs untreated HIV- infected cells. Our results demonstrate that: 1) By direct immunofluorescence 3 to 8% of PBMCs are CD25+, whereas by indirect immunofluorescence 30% are CD25+. The increased number of CD25+ cells is due to their detection by the highly sensitive indirect immunofluorescence assay. Up to 60% of the CD25+ cells are CD4+ and 12% are CD8+. 2) Treatment of HIV-infected PBMCs with an anti-CD25 IT for 6 days eliminated both CD25high and CD25low cells and decreased the production of p24 by 99%. 3) Differences in the HIV proviral genome were detected in the unfractionated PBMCs vs PBMCs from which CD25+ cells had been eliminated by IT treatment. Hence, PBMCs containing both CD25+ and CD25- cells express all intermediate proviral species and full-length double-stranded proviral DNA. In contrast, CD25- quiescent cells contain predominantly intermediate species. These results confirm and extend our previous observations that expression of CD25 can distinguish latently infected cells from cells producing virus.
This article has been cited by other articles:
|
|
 |
|
  A. Joshi, H. Garg, M. B. Tompkins, and W. A. Tompkins Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of FIV Long Terminal Repeat Binding Cellular Transcriptional Factors J. Virol., April 15, 2005; 79(8): 4965 - 4976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Saavedra-Lozano, C. C. McCoig, Y. Cao, E. S. Vitetta, and O. Ramilo Zidovudine, Lamivudine, and Abacavir Have Different Effects on Resting Cells Infected with Human Immunodeficiency Virus In Vitro Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2825 - 2830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Brooks and J. A. Zack Effect of Latent Human Immunodeficiency Virus Infection on Cell Surface Phenotype J. Virol., February 15, 2002; 76(4): 1673 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. De Paoli Immunological Effects of Interleukin-2 Therapy in Human Immunodeficiency Virus-Positive Subjects Clin. Vaccine Immunol., July 1, 2001; 8(4): 671 - 677. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Veazey, K. G. Mansfield, I. C. Tham, A. C. Carville, D. E. Shvetz, A. E. Forand, and A. A. Lackner Dynamics of CCR5 Expression by CD4+ T Cells in Lymphoid Tissues during Simian Immunodeficiency Virus Infection J. Virol., December 1, 2000; 74(23): 11001 - 11007. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Veazey, I. C. Tham, K. G. Mansfield, M. DeMaria, A. E. Forand, D. E. Shvetz, L. V. Chalifoux, P. K. Sehgal, and A. A. Lackner Identifying the Target Cell in Primary Simian Immunodeficiency Virus (SIV) Infection: Highly Activated Memory CD4+ T Cells Are Rapidly Eliminated in Early SIV Infection In Vivo J. Virol., January 1, 2000; 74(1): 57 - 64. [Abstract] [Full Text]
|
|
|
|
|
|
V. Vieillard, S. Jouveshomme, N. Leflour, E. Jean-Pierre, P. Debre, E. De Maeyer, and B. Autran Transfer of Human CD4+ T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection J. Virol., December 1, 1999; 73(12): 10281 - 10288. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. McCoig, G. Van Dyke, C.-S. Chou, L. J. Picker, O. Ramilo, and E. S. Vitetta An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro PNAS, September 28, 1999; 96(20): 11482 - 11485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Hengel, B. M. Jones, M. S. Kennedy, M. R. Hubbard, and J. S. McDougal Markers of Lymphocyte Homing Distinguish CD4 T Cell Subsets That Turn Over in Response to HIV-1 Infection in Humans J. Immunol., September 15, 1999; 163(6): 3539 - 3548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Morse, N. Sakaguchi, and S. Sakaguchi Virus and Autoimmunity: Induction of Autoimmune Disease in Mice by Mouse T Lymphotropic Virus (MTLV) Destroying CD4+ T Cells J. Immunol., May 1, 1999; 162(9): 5309 - 5316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Li, Y. Ueda, B. Shi, L. Borodyansky, L. Huang, Y.-Z. Li, and A. B. Pardee Tat protein induces self-perpetuating permissivity for productive HIV-1 infection PNAS, July 22, 1997; 94(15): 8116 - 8120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Chou, O. Ramilo, and E. S. Vitetta Highly purified CD25- resting T cells cannot be infected de novo with HIV-1 PNAS, February 18, 1997; 94(4): 1361 - 1365. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
